Johnson & Johnson To Build $1 Billion Campus In Montco

LOWER GWYNEDD, PA — Pharmaceutical and medical giant Johnson & Johnson will build a massive $1 billion campus in Montgomery County, they announced this week.

The company is calling it an "advanced manufacturing site" to build out stem cell therapy technologies. It will be located on Sumneytown Pike in the Spring House section of Lower Gwynedd Township.

The project is estimated to bring 4,000 new, temporary construction jobs and 500 permanent biomanufacturing jobs to the area.

“For 140 years, Johnson & Johnson has been a leading innovator in American healthcare, and we are honored to continue advancing that legacy in Pennsylvania,” Johnson and Johnson CEO Joaquin Duato said in a statement.

The state provided massive incentives to the company to build in Pennsylvania, including $12 million in tax credits through the Qualified Manufacturing Innovation and Reinvestment Deduction program, to $2 million in tax credits through the Manufacturing Tax Credit program, a $15 million grant through the PA SITES program, and a $10 million Pennsylvania First grant.

The facility is part of the company's pledged $55 billion investment in U.S. projects by 2029. The company says it will help them "deliver...(their) portfolio of transformational medicines." Pennsylvania officials pointed to cancer, immune-mediated, and neurological disease applications.

No information on the construction timeline has been made available.

Pennsylvania's U.S. Sen. Dave McCormick said the company's selection of Pennsylvania is a reflection of the state's strength.

“Pennsylvania leads in life sciences and advanced manufacturing because we consistently deliver what companies like Johnson and Johnson need to succeed," McCormick said. "A skilled workforce, premier research institutions, and proven manufacturing strength."

Johnson & Johnson already has 10 facilities around Pennsylvania, with dedicated manufacturing, research, and office operations all centered locally.